Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

METABOLISM

LEAP2: A novel regulator of food intake and body weight?

A new study is the first to investigate the relationship between liver-enriched antimicrobial peptide-2 (LEAP2) and different metabolic states, and highlights the reciprocal relationship between LEAP2 and ghrelin (known as the ‘hunger hormone’ for its role in stimulating appetite). These findings could have important implications given the worldwide increase in obesity since 1975.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Pharmacological modulation of ghrelin and GHSR.

References

  1. Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660 (1999).

    Article  CAS  Google Scholar 

  2. Ge, X. et al. LEAP2 is an endogenous antagonist of the ghrelin receptor. Cell. Metabolism 27, 461–469.e6 (2018).

    Article  CAS  Google Scholar 

  3. Mani, B. K. et al. LEAP2 changes with body mass and food intake in humans and mice. J. Clin. Invest. 129, 3909–3923 (2019).

    Article  Google Scholar 

  4. Cornejo, M. P. et al. Growth hormone secretagogue receptor signaling affects high fat intake independently of plasma levels of ghrelin and leap2, in a 4-day binge eating model. J. Neuroendocrinol. https://doi.org/10.1111/jne.12785 (2019).

    Article  PubMed  Google Scholar 

  5. M’Kadmi, C. et al. N-terminal liver-expressed antimicrobial peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor. J. Med. Chem. 62, 965–973 (2019).

    Article  Google Scholar 

  6. Wang, J. H. et al. Identifying the binding mechanism of LEAP2 to receptor GHSR1a. FEBS J. 286, 1332–1345 (2019).

    Article  CAS  Google Scholar 

  7. Schalla, M. A. & Stengel, A. Pharmacological modulation of ghrelin to induce weight loss: successes and challenges current diabetes reports. Curr. Diabetes Rep. 19, 102 (2019).

    Article  Google Scholar 

  8. Schalla, M. A. & Stengel, A. The role of ghrelin in anorexia nervosa. Int. J. Mol. Sci. 19, 2117 (2018).

    Article  Google Scholar 

  9. Henriques, S. T., Tan, C. C., Craik, D. J. & Clark, R. J. Structural and functional analysis of human liver-expressed antimicrobial peptide 2. Chembiochem 11, 2148–2157 (2010).

    Article  CAS  Google Scholar 

  10. World Health Organization. Obesity and Overweight. Who.int https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (2018).

Download references

Acknowledgements

The work of the authors is supported by funding of the German Research Foundation (STE 1765/3-2) and Charité University Funding (UFF 89/441-176, A.S.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas Stengel.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schalla, M.A., Stengel, A. LEAP2: A novel regulator of food intake and body weight?. Nat Rev Gastroenterol Hepatol 16, 711–712 (2019). https://doi.org/10.1038/s41575-019-0224-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-019-0224-9

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing